A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer's disease.
Introduction: Current prescribing guidelines for the antipsychotic amisulpride are based largely on pharmacokinetic (PK) studies in young adults, and there is a relative absence of data on older patients, who are at greatest risk of developing adverse events. Methods: This study aimed to develop a p...
| Publicado en: | Psychopharmacology Vol. 233; no. 18; pp. 3371 - 3382 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Sep2016
|
| Acceso en línea: | Ver este registro en EBSCOhost |